MS
DICE

Maven Securities’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Maven Securities’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,700
Closed -$265K – 1252
2023
Q2 		$265K Buy
+5,700
New +$197K ﹤0.01% 764

Maven Securities's DICE Position: Q4 2021 in Review

Maven Securities sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q4 2021, closing a stake of 8,065 shares — an estimated $264K sold.

Maven Securities first reported a position in DICE in Q3 2021 and held it in 1 quarter. The position peaked at $264K in Q3 2021. 69 funds tracked by Wall St. Rank hold DICE as of Q4 2021.

  • Maven Securities reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Maven Securities sold 8,065 DICE Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $264K.
  • Maven Securities first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Maven Securities's DICE Therapeutics, Inc. Common Stock position peaked at $264K in Q3 2021.
  • 69 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Maven Securities's 13F filing for Q4 2021, filed 14 Feb 2022.